18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile

An aberrant pro-inflammatory microglia response has been associated with most neurodegenerative disorders. Identifying microglia druggable checkpoints to restore their physiological functions is an emerging challenge. Recent data have shown that microglia produce de novo neurosteroids, endogenous mo...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular and molecular life sciences : CMLS 2025-01, Vol.82 (1), p.34, Article 34
Hauptverfasser: Germelli, Lorenzo, Angeloni, Elisa, Da Pozzo, Eleonora, Tremolanti, Chiara, De Felice, Martina, Giacomelli, Chiara, Marchetti, Laura, Muscatello, Beatrice, Barresi, Elisabetta, Taliani, Sabrina, Da Settimo Passetti, Federico, Trincavelli, Maria Letizia, Martini, Claudia, Costa, Barbara
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 1
container_start_page 34
container_title Cellular and molecular life sciences : CMLS
container_volume 82
creator Germelli, Lorenzo
Angeloni, Elisa
Da Pozzo, Eleonora
Tremolanti, Chiara
De Felice, Martina
Giacomelli, Chiara
Marchetti, Laura
Muscatello, Beatrice
Barresi, Elisabetta
Taliani, Sabrina
Da Settimo Passetti, Federico
Trincavelli, Maria Letizia
Martini, Claudia
Costa, Barbara
description An aberrant pro-inflammatory microglia response has been associated with most neurodegenerative disorders. Identifying microglia druggable checkpoints to restore their physiological functions is an emerging challenge. Recent data have shown that microglia produce de novo neurosteroids, endogenous molecules exerting potent anti-inflammatory activity. Here, the role of neurosteroidogenesis in the modulation of microgliosis was explored in human microglia cells. In particular, CYP11A1 inhibition or TSPO pharmacological stimulation, crucial proteins involved in the rate limiting step of the neurosteroidogenic cascade, were employed. CYP11A1 inhibition led microglia to acquire a dysfunctional and hyperreactive phenotype, while selective TSPO ligands promoted the establishment of an anti-inflammatory one. Analysis of specific neurosteroid levels (neurosteroidome) identified allopregnanolone/pregnanolone as crucial metabolites allowing controlled activation of microglia. Importantly, the neurosteroid shift towards a greater androgenic/estrogenic profile supported the transition from pro-inflammatory to neuroprotective microglia, suggesting the therapeutic potential of de novo microglial neurosteroidogenesis stimulation for neuroinflammatory-related disorders.
doi_str_mv 10.1007/s00018-024-05544-1
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11700965</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3151876198</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2631-198450ff5e23a698b96173c8fdbee3fe0de24cc5090c0a7788424879ebf694273</originalsourceid><addsrcrecordid>eNp9kc1u1TAQhSNERUvhBVggS2zYhI4dO7ZXCLX8SZWKRFlbvs4kdUnsi50UwdPwLDwZvvf2DxasbGu-OTPHp6qeUXhFAeRRBgCqamC8BiE4r-mD6oByBrUGSR_eu-9Xj3O-LLRQrH1U7TdaCskUPahmqn7_-npiyfnnT2dktmnA2YeBdMlfYSbrONrkf2JHLpbJBjJ5l-Iwekvm-N2mLhNL1inO6ObCExs6kjDPMdntO-CSYp4xRd_FCTdo70d8Uu31dsz49Po8rL68e3t-_KE-PXv_8fjNae1Y29CaasUF9L1A1thWq5VuqWyc6rsVYtMjdMi4cwI0OLBSKsUZV1Ljqm81Z7I5rF7vdNfLasLOYZiTHc06-cmmHyZab_6uBH9hhnhlKJUAuhVF4eW1QorfluLMTD47HEcbMC7ZNFRQJduyaUFf_INexiWF4m9LSSU0bCi2o8o_5pywv92GgtmkanapmpKq2aZqaGl6ft_HbctNjAVodkAupTBgupv9H9k_6D2v2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3151785908</pqid></control><display><type>article</type><title>18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile</title><source>Springer Nature OA Free Journals</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>SpringerLink Journals - AutoHoldings</source><creator>Germelli, Lorenzo ; Angeloni, Elisa ; Da Pozzo, Eleonora ; Tremolanti, Chiara ; De Felice, Martina ; Giacomelli, Chiara ; Marchetti, Laura ; Muscatello, Beatrice ; Barresi, Elisabetta ; Taliani, Sabrina ; Da Settimo Passetti, Federico ; Trincavelli, Maria Letizia ; Martini, Claudia ; Costa, Barbara</creator><creatorcontrib>Germelli, Lorenzo ; Angeloni, Elisa ; Da Pozzo, Eleonora ; Tremolanti, Chiara ; De Felice, Martina ; Giacomelli, Chiara ; Marchetti, Laura ; Muscatello, Beatrice ; Barresi, Elisabetta ; Taliani, Sabrina ; Da Settimo Passetti, Federico ; Trincavelli, Maria Letizia ; Martini, Claudia ; Costa, Barbara</creatorcontrib><description>An aberrant pro-inflammatory microglia response has been associated with most neurodegenerative disorders. Identifying microglia druggable checkpoints to restore their physiological functions is an emerging challenge. Recent data have shown that microglia produce de novo neurosteroids, endogenous molecules exerting potent anti-inflammatory activity. Here, the role of neurosteroidogenesis in the modulation of microgliosis was explored in human microglia cells. In particular, CYP11A1 inhibition or TSPO pharmacological stimulation, crucial proteins involved in the rate limiting step of the neurosteroidogenic cascade, were employed. CYP11A1 inhibition led microglia to acquire a dysfunctional and hyperreactive phenotype, while selective TSPO ligands promoted the establishment of an anti-inflammatory one. Analysis of specific neurosteroid levels (neurosteroidome) identified allopregnanolone/pregnanolone as crucial metabolites allowing controlled activation of microglia. Importantly, the neurosteroid shift towards a greater androgenic/estrogenic profile supported the transition from pro-inflammatory to neuroprotective microglia, suggesting the therapeutic potential of de novo microglial neurosteroidogenesis stimulation for neuroinflammatory-related disorders.</description><identifier>ISSN: 1420-9071</identifier><identifier>ISSN: 1420-682X</identifier><identifier>EISSN: 1420-9071</identifier><identifier>DOI: 10.1007/s00018-024-05544-1</identifier><identifier>PMID: 39757281</identifier><language>eng</language><publisher>Cham: Springer International Publishing</publisher><subject>Anti-inflammatory agents ; Biochemistry ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Enzymes ; Genotype &amp; phenotype ; Life Sciences ; Ligands ; Metabolites ; Microglia ; Morphology ; Neurodegeneration ; Neurodegenerative diseases ; Neuromodulation ; Neuroprotection ; Neurosciences ; Neurosteroidogenesis ; Neurosteroids ; Original ; Original Article ; Phenotypes ; Physiology ; Pregnanolone ; Stimulation ; Xenoestrogens</subject><ispartof>Cellular and molecular life sciences : CMLS, 2025-01, Vol.82 (1), p.34, Article 34</ispartof><rights>The Author(s) 2025</rights><rights>2025. The Author(s).</rights><rights>Copyright Springer Nature B.V. Dec 2025</rights><rights>The Author(s) 2025 2025</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c2631-198450ff5e23a698b96173c8fdbee3fe0de24cc5090c0a7788424879ebf694273</cites><orcidid>0000-0002-6244-602X ; 0000-0002-6122-7327 ; 0000-0001-7704-8705 ; 0000-0002-7897-7917 ; 0000-0002-7318-7545 ; 0000-0001-9379-3027 ; 0000-0002-3113-7099 ; 0000-0002-9814-7195 ; 0000-0001-8675-939X ; 0000-0002-2110-9481 ; 0000-0001-8124-977X ; 0000-0002-7598-1275 ; 0000-0003-4762-8949</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700965/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11700965/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,41099,41467,42168,42536,51297,51554,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39757281$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Germelli, Lorenzo</creatorcontrib><creatorcontrib>Angeloni, Elisa</creatorcontrib><creatorcontrib>Da Pozzo, Eleonora</creatorcontrib><creatorcontrib>Tremolanti, Chiara</creatorcontrib><creatorcontrib>De Felice, Martina</creatorcontrib><creatorcontrib>Giacomelli, Chiara</creatorcontrib><creatorcontrib>Marchetti, Laura</creatorcontrib><creatorcontrib>Muscatello, Beatrice</creatorcontrib><creatorcontrib>Barresi, Elisabetta</creatorcontrib><creatorcontrib>Taliani, Sabrina</creatorcontrib><creatorcontrib>Da Settimo Passetti, Federico</creatorcontrib><creatorcontrib>Trincavelli, Maria Letizia</creatorcontrib><creatorcontrib>Martini, Claudia</creatorcontrib><creatorcontrib>Costa, Barbara</creatorcontrib><title>18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile</title><title>Cellular and molecular life sciences : CMLS</title><addtitle>Cell. Mol. Life Sci</addtitle><addtitle>Cell Mol Life Sci</addtitle><description>An aberrant pro-inflammatory microglia response has been associated with most neurodegenerative disorders. Identifying microglia druggable checkpoints to restore their physiological functions is an emerging challenge. Recent data have shown that microglia produce de novo neurosteroids, endogenous molecules exerting potent anti-inflammatory activity. Here, the role of neurosteroidogenesis in the modulation of microgliosis was explored in human microglia cells. In particular, CYP11A1 inhibition or TSPO pharmacological stimulation, crucial proteins involved in the rate limiting step of the neurosteroidogenic cascade, were employed. CYP11A1 inhibition led microglia to acquire a dysfunctional and hyperreactive phenotype, while selective TSPO ligands promoted the establishment of an anti-inflammatory one. Analysis of specific neurosteroid levels (neurosteroidome) identified allopregnanolone/pregnanolone as crucial metabolites allowing controlled activation of microglia. Importantly, the neurosteroid shift towards a greater androgenic/estrogenic profile supported the transition from pro-inflammatory to neuroprotective microglia, suggesting the therapeutic potential of de novo microglial neurosteroidogenesis stimulation for neuroinflammatory-related disorders.</description><subject>Anti-inflammatory agents</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Enzymes</subject><subject>Genotype &amp; phenotype</subject><subject>Life Sciences</subject><subject>Ligands</subject><subject>Metabolites</subject><subject>Microglia</subject><subject>Morphology</subject><subject>Neurodegeneration</subject><subject>Neurodegenerative diseases</subject><subject>Neuromodulation</subject><subject>Neuroprotection</subject><subject>Neurosciences</subject><subject>Neurosteroidogenesis</subject><subject>Neurosteroids</subject><subject>Original</subject><subject>Original Article</subject><subject>Phenotypes</subject><subject>Physiology</subject><subject>Pregnanolone</subject><subject>Stimulation</subject><subject>Xenoestrogens</subject><issn>1420-9071</issn><issn>1420-682X</issn><issn>1420-9071</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2025</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><recordid>eNp9kc1u1TAQhSNERUvhBVggS2zYhI4dO7ZXCLX8SZWKRFlbvs4kdUnsi50UwdPwLDwZvvf2DxasbGu-OTPHp6qeUXhFAeRRBgCqamC8BiE4r-mD6oByBrUGSR_eu-9Xj3O-LLRQrH1U7TdaCskUPahmqn7_-npiyfnnT2dktmnA2YeBdMlfYSbrONrkf2JHLpbJBjJ5l-Iwekvm-N2mLhNL1inO6ObCExs6kjDPMdntO-CSYp4xRd_FCTdo70d8Uu31dsz49Po8rL68e3t-_KE-PXv_8fjNae1Y29CaasUF9L1A1thWq5VuqWyc6rsVYtMjdMi4cwI0OLBSKsUZV1Ljqm81Z7I5rF7vdNfLasLOYZiTHc06-cmmHyZab_6uBH9hhnhlKJUAuhVF4eW1QorfluLMTD47HEcbMC7ZNFRQJduyaUFf_INexiWF4m9LSSU0bCi2o8o_5pywv92GgtmkanapmpKq2aZqaGl6ft_HbctNjAVodkAupTBgupv9H9k_6D2v2A</recordid><startdate>20250106</startdate><enddate>20250106</enddate><creator>Germelli, Lorenzo</creator><creator>Angeloni, Elisa</creator><creator>Da Pozzo, Eleonora</creator><creator>Tremolanti, Chiara</creator><creator>De Felice, Martina</creator><creator>Giacomelli, Chiara</creator><creator>Marchetti, Laura</creator><creator>Muscatello, Beatrice</creator><creator>Barresi, Elisabetta</creator><creator>Taliani, Sabrina</creator><creator>Da Settimo Passetti, Federico</creator><creator>Trincavelli, Maria Letizia</creator><creator>Martini, Claudia</creator><creator>Costa, Barbara</creator><general>Springer International Publishing</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SS</scope><scope>7T5</scope><scope>7T7</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U7</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-6244-602X</orcidid><orcidid>https://orcid.org/0000-0002-6122-7327</orcidid><orcidid>https://orcid.org/0000-0001-7704-8705</orcidid><orcidid>https://orcid.org/0000-0002-7897-7917</orcidid><orcidid>https://orcid.org/0000-0002-7318-7545</orcidid><orcidid>https://orcid.org/0000-0001-9379-3027</orcidid><orcidid>https://orcid.org/0000-0002-3113-7099</orcidid><orcidid>https://orcid.org/0000-0002-9814-7195</orcidid><orcidid>https://orcid.org/0000-0001-8675-939X</orcidid><orcidid>https://orcid.org/0000-0002-2110-9481</orcidid><orcidid>https://orcid.org/0000-0001-8124-977X</orcidid><orcidid>https://orcid.org/0000-0002-7598-1275</orcidid><orcidid>https://orcid.org/0000-0003-4762-8949</orcidid></search><sort><creationdate>20250106</creationdate><title>18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile</title><author>Germelli, Lorenzo ; Angeloni, Elisa ; Da Pozzo, Eleonora ; Tremolanti, Chiara ; De Felice, Martina ; Giacomelli, Chiara ; Marchetti, Laura ; Muscatello, Beatrice ; Barresi, Elisabetta ; Taliani, Sabrina ; Da Settimo Passetti, Federico ; Trincavelli, Maria Letizia ; Martini, Claudia ; Costa, Barbara</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2631-198450ff5e23a698b96173c8fdbee3fe0de24cc5090c0a7788424879ebf694273</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2025</creationdate><topic>Anti-inflammatory agents</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Enzymes</topic><topic>Genotype &amp; phenotype</topic><topic>Life Sciences</topic><topic>Ligands</topic><topic>Metabolites</topic><topic>Microglia</topic><topic>Morphology</topic><topic>Neurodegeneration</topic><topic>Neurodegenerative diseases</topic><topic>Neuromodulation</topic><topic>Neuroprotection</topic><topic>Neurosciences</topic><topic>Neurosteroidogenesis</topic><topic>Neurosteroids</topic><topic>Original</topic><topic>Original Article</topic><topic>Phenotypes</topic><topic>Physiology</topic><topic>Pregnanolone</topic><topic>Stimulation</topic><topic>Xenoestrogens</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Germelli, Lorenzo</creatorcontrib><creatorcontrib>Angeloni, Elisa</creatorcontrib><creatorcontrib>Da Pozzo, Eleonora</creatorcontrib><creatorcontrib>Tremolanti, Chiara</creatorcontrib><creatorcontrib>De Felice, Martina</creatorcontrib><creatorcontrib>Giacomelli, Chiara</creatorcontrib><creatorcontrib>Marchetti, Laura</creatorcontrib><creatorcontrib>Muscatello, Beatrice</creatorcontrib><creatorcontrib>Barresi, Elisabetta</creatorcontrib><creatorcontrib>Taliani, Sabrina</creatorcontrib><creatorcontrib>Da Settimo Passetti, Federico</creatorcontrib><creatorcontrib>Trincavelli, Maria Letizia</creatorcontrib><creatorcontrib>Martini, Claudia</creatorcontrib><creatorcontrib>Costa, Barbara</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Cellular and molecular life sciences : CMLS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Germelli, Lorenzo</au><au>Angeloni, Elisa</au><au>Da Pozzo, Eleonora</au><au>Tremolanti, Chiara</au><au>De Felice, Martina</au><au>Giacomelli, Chiara</au><au>Marchetti, Laura</au><au>Muscatello, Beatrice</au><au>Barresi, Elisabetta</au><au>Taliani, Sabrina</au><au>Da Settimo Passetti, Federico</au><au>Trincavelli, Maria Letizia</au><au>Martini, Claudia</au><au>Costa, Barbara</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile</atitle><jtitle>Cellular and molecular life sciences : CMLS</jtitle><stitle>Cell. Mol. Life Sci</stitle><addtitle>Cell Mol Life Sci</addtitle><date>2025-01-06</date><risdate>2025</risdate><volume>82</volume><issue>1</issue><spage>34</spage><pages>34-</pages><artnum>34</artnum><issn>1420-9071</issn><issn>1420-682X</issn><eissn>1420-9071</eissn><abstract>An aberrant pro-inflammatory microglia response has been associated with most neurodegenerative disorders. Identifying microglia druggable checkpoints to restore their physiological functions is an emerging challenge. Recent data have shown that microglia produce de novo neurosteroids, endogenous molecules exerting potent anti-inflammatory activity. Here, the role of neurosteroidogenesis in the modulation of microgliosis was explored in human microglia cells. In particular, CYP11A1 inhibition or TSPO pharmacological stimulation, crucial proteins involved in the rate limiting step of the neurosteroidogenic cascade, were employed. CYP11A1 inhibition led microglia to acquire a dysfunctional and hyperreactive phenotype, while selective TSPO ligands promoted the establishment of an anti-inflammatory one. Analysis of specific neurosteroid levels (neurosteroidome) identified allopregnanolone/pregnanolone as crucial metabolites allowing controlled activation of microglia. Importantly, the neurosteroid shift towards a greater androgenic/estrogenic profile supported the transition from pro-inflammatory to neuroprotective microglia, suggesting the therapeutic potential of de novo microglial neurosteroidogenesis stimulation for neuroinflammatory-related disorders.</abstract><cop>Cham</cop><pub>Springer International Publishing</pub><pmid>39757281</pmid><doi>10.1007/s00018-024-05544-1</doi><orcidid>https://orcid.org/0000-0002-6244-602X</orcidid><orcidid>https://orcid.org/0000-0002-6122-7327</orcidid><orcidid>https://orcid.org/0000-0001-7704-8705</orcidid><orcidid>https://orcid.org/0000-0002-7897-7917</orcidid><orcidid>https://orcid.org/0000-0002-7318-7545</orcidid><orcidid>https://orcid.org/0000-0001-9379-3027</orcidid><orcidid>https://orcid.org/0000-0002-3113-7099</orcidid><orcidid>https://orcid.org/0000-0002-9814-7195</orcidid><orcidid>https://orcid.org/0000-0001-8675-939X</orcidid><orcidid>https://orcid.org/0000-0002-2110-9481</orcidid><orcidid>https://orcid.org/0000-0001-8124-977X</orcidid><orcidid>https://orcid.org/0000-0002-7598-1275</orcidid><orcidid>https://orcid.org/0000-0003-4762-8949</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1420-9071
ispartof Cellular and molecular life sciences : CMLS, 2025-01, Vol.82 (1), p.34, Article 34
issn 1420-9071
1420-682X
1420-9071
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_11700965
source Springer Nature OA Free Journals; PubMed Central; Alma/SFX Local Collection; SpringerLink Journals - AutoHoldings
subjects Anti-inflammatory agents
Biochemistry
Biomedical and Life Sciences
Biomedicine
Cell Biology
Enzymes
Genotype & phenotype
Life Sciences
Ligands
Metabolites
Microglia
Morphology
Neurodegeneration
Neurodegenerative diseases
Neuromodulation
Neuroprotection
Neurosciences
Neurosteroidogenesis
Neurosteroids
Original
Original Article
Phenotypes
Physiology
Pregnanolone
Stimulation
Xenoestrogens
title 18 kDa TSPO targeting drives polarized human microglia towards a protective and restorative neurosteroidome profile
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T09%3A47%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=18%C2%A0kDa%20TSPO%20targeting%20drives%20polarized%20human%20microglia%20towards%20a%20protective%20and%20restorative%20neurosteroidome%20profile&rft.jtitle=Cellular%20and%20molecular%20life%20sciences%20:%20CMLS&rft.au=Germelli,%20Lorenzo&rft.date=2025-01-06&rft.volume=82&rft.issue=1&rft.spage=34&rft.pages=34-&rft.artnum=34&rft.issn=1420-9071&rft.eissn=1420-9071&rft_id=info:doi/10.1007/s00018-024-05544-1&rft_dat=%3Cproquest_pubme%3E3151876198%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3151785908&rft_id=info:pmid/39757281&rfr_iscdi=true